September 16, 2020
This letter briefly elaborates four areas we believe the Roadmap should focus on in order to retain Europe’s competitiveness and ensure health-related innovation meets the future needs of Europe’s population:
- Maintain high standards of IP protection to promote economic growth and protect the EU’s global competitiveness
- Strengthen the EU’s innovation ecosystem by ensuring all publicly-funded research institutions can license and profit from their research
- Reform the patent system to strengthen R&D incentives for the diseases of aging and other unmet needs
- Ensure GDPR does not present a barrier to data-driven drug development in the EU.